Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. (PACB) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
PACB · net income · updated Jun 9, 2026
Core profitability metrics
PACB · net income · margin · TTM · CAGRNet income was −$546.4M for FY2025 (fiscal year ending 2025-12-31), down 76.3% year-over-year. Net profit margin was -341.5%. Based on available data, Pacific Biosciences of California, Inc. has been profitable since at least 2020.
Annual net income history
▸ FMP /income-statement · Annual · PACB net income history · PACB profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Pacific Biosciences of California, Inc. (PACB) reported net income of −$546.4M for FY2025 (fiscal year ending 2025-12-31), down 76.3% year-over-year. The net profit margin was -341.5% — meaning the company kept $-3.41 of every dollar of revenue as profit.
Based on available data, Pacific Biosciences of California, Inc. has been profitable since at least 2020. Net income reached a peak of $29.4M in FY2020. Data available for 15 fiscal years.
Pacific Biosciences of California, Inc.'s net profit margin was -341.5% for FY2025, based on the latest annual results.
Investors sometimes search for "Pacific Biosciences of California, Inc. net worth" — the company's market capitalization is a separate figure from PACB net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
PACB net income · 4 questionsPacific Biosciences of California, Inc. is not currently profitable on an annual basis. The company reported a net loss of $546.4M for FY2025.
▸ Source: FMP /income-statement · GAAP · Pacific Biosciences of California, Inc. · Pacific Biosciences of California, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026